Oral propranolol in infantile hemangiomas: Analysis of factors that affect the outcome

• Egile Nagusiak: Arun Mohanan Ainipully (Egilea), Sarath Kumar Narayanan (Egilea), Arun Preeth Vazhiyodan (Egilea), Prathap Somnath (Egilea)
• Formatua: Liburua
• Argitaratua: Wolters Kluwer Medknow Publications, 2019-01-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Aim: The primary treatment for the subset of infantile hemangiomas (IHs) which develops complication is pharmacological intervention, and propranolol has become a popular choice. Here, we evaluated the efficacy and safety of propranolol in a clinical cohort of IHs and analyzed clinical characteristi...